샘플 요청 목록

 카트 문의
시장보고서
상품코드
1742891

세계의 기침약 시장

Cough Remedy
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 383 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 기침약 시장은 2030년까지 12억 달러에 이를 전망

2024년에 10억 달러로 추정되는 기침을 멈추는 세계 시장은 2024-2030년간 CAGR 2.6%로 성장하여 2030년에는 12억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 거담제는 CAGR 3.1%를 나타내고, 분석 기간 종료시에는 5억 7,330만 달러에 이를 것으로 예측됩니다. 항히스타민제 부문의 성장률은 분석 기간중 CAGR 2.9%로 추정됩니다.

미국 시장은 2억 8,120만 달러로 추정, 중국은 CAGR 5.1%로 성장 예측

미국의 기침약 시장은 2024년에 2억 8,120만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년 CAGR 5.1%로 성장하여 2030년까지 2억 3,300만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 0.9%와 2.0%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.4%를 보일 전망입니다.

세계의 기침약 시장 - 주요 동향과 촉진요인 정리

왜 기침약은 세계 헬스케어 및 웰니스 시장에서 지속적인 부문인가?

기침은 모든 연령대와 지역에서 보편적이고 반복적으로 발생하기 때문에 기침약은 OTC 헬스케어 제품의 중요한 구성 요소로 남아 있습니다. 감기, 알레르기, 천식, 독감, 환경 오염 물질 등 기침은 증상 완화를 원하는 사람들에게 가장 흔한 증상 중 하나입니다. 이러한 지속적인 수요로 인해 기침 시럽, 가래제, 거담제, 충혈 완화제, 복합제 시장은 안정적이며, OTC 기침약은 약국, 슈퍼마켓, 온라인 플랫폼에서 쉽게 구할 수 있기 때문에 전 세계적으로 가장 많이 구매되는 셀프 케어 솔루션 중 하나가 되었습니다. 또한, 건강에 대한 인식이 높아지면서 호흡기 증상에 대한 조기 치료가 증가하고 있으며, 가정 내 상비약 상자에 기침약을 구비하는 소비자들이 증가하고 있습니다. 특히 겨울과 독감 시즌에는 호흡기 감염증이 계절적으로 급증하기 때문에 수요가 지속적으로 증가하고 있습니다. 특히 어린이와 노년층은 강한 부작용 없이 증상을 완화할 수 있는 순하고 특수한 제제에 크게 의존하고 있습니다. 또한, 시장은 약초, 천연, 무설탕으로 진화하여 온화하고 전체적인 건강 관리에 대한 선호도가 높아짐에 따라 진화하고 있습니다. 기침약은 일선 증상 완화제이자 일상적인 건강 습관에 깊숙이 침투한 제품으로서, 기침약은 전 세계 제약 및 소비자 의약품 포트폴리오에 필수적이고 많은 양을 차지하는 카테고리로 남아 있습니다.

소비자 취향의 변화와 라이프스타일의 변화는 기침약 시장에 어떤 영향을 미치고 있는가?

기침약 시장은 빠른 효과, 졸음 방지, 자연스럽고 개인 맞춤형 치료법을 선호하는 현대 소비자 행동에 의해 점점 더 많은 시장이 형성되고 있습니다. 소비자들이 성분에 대한 인식이 높아지면서 꿀, 생강, 멘톨, 유칼립투스, 아이비 잎, 감초 뿌리와 같은 천연 성분을 특징으로 하는 치료제로의 전환이 두드러지게 나타나고 있으며, 많은 경우 화학 기반 의약품보다 더 안전하고 부드러운 대안으로 인식되고 있습니다. 이러한 추세는 특히 밀레니얼 세대와 어린 자녀를 둔 부모들 사이에서 두드러지게 나타나고 있으며, 이들은 합성 첨가물이 적은 천연 성분을 선호합니다. 또한, 바쁜 라이프 스타일은 용해 가능한 스트립, 마름모꼴, 1회분씩 복용할 수 있는 파우치 등 휴대가 간편하고 사용하기 쉬운 형태에 대한 수요를 촉진하고 있습니다. 동시에 디지털 웰빙 문화와 자가 진단 습관으로 인해 소비자들은 증상의 특이성에 따라 치료제를 스스로 선택하게 되었고, 브랜드는 마른 기침과 가슴 아픈 기침, 주간용과 야간용 등 명확하게 세분화된 제품을 제공하게 되었습니다. 비건, 무설탕, 무설탕, 무글루텐, 무알코올 표시는 다양한 식습관과 윤리적 소비자 그룹에 대한 어필을 더욱 강화하고 있으며, 코로나19 이후 호흡기 건강에 대한 인식이 높아지면서 경미한 증상일지라도 선제적으로 치료하는 경향이 높아졌습니다. 보다 신중한 행동을 보이게 되었습니다. 이러한 선호도 변화는 제약회사와 웰니스 브랜드가 보다 깨끗한 라벨, 다양한 효능, 편리한 전달 시스템 등 혁신을 통해 기침약의 처방, 판매 및 소비 방식을 재편하고 있습니다.

기침약의 효과와 안전성을 형성하는 혁신과 규제 개발은 무엇인가?

기침약 시장의 기술 혁신은 약리학적 처방과 식물학 연구부터 규제 감독과 제조 기술에 이르기까지 다방면으로 발전하고 있습니다. 과학자들과 제조업체들은 졸음이나 위장 장애와 같은 부작용을 최소화하면서 효능을 높이기 위해 합성 및 식물 유래의 새로운 활성 성분을 지속적으로 탐색하고 있습니다. 최근 제제는 치료를 간소화하고 환자의 순응도를 높이기 위해 여러 작용(거담제, 항히스타민제, 진해제 등)을 한 번에 복용할 수 있는 복합제제인 경우가 많습니다. 또한, 성분의 치료 효과를 더 오래 지속시키고 투여 횟수를 줄여 편의성을 높이기 위해 캡슐화 기술이나 시간 방출 기술이 개발되고 있습니다. 규제 측면에서는 FDA(미국), EMA(유럽), MHRA(영국) 등의 기관에서 코데인, 덱스트로메토르판 등 특정 성분에 대해 특히 청소년의 오남용을 우려하여 규제를 강화하고 있습니다. 이에 따라 안전하고 중독성이 없는 대체품, 용법-용량에 대한 명확한 표시가 점점 더 강조되고 있으며, GMP(의약품 제조관리 및 품질관리 기준) 및 ISO(국제표준화기구) 표준과 같은 품질 인증은 현재 기존 의약품 및 한약제제 제조업체의 기본 요건이 되고 있습니다. 신흥 시장에서는 개선된 규제 프레임워크와 공중보건에 대한 투자 증가로 인해 보다 신뢰할 수 있고, 검증되고, 규정을 준수하는 제품을 도입할 수 있는 여건이 조성되고 있습니다. 이러한 발전으로 기침약은 효능에 대한 현대인의 기대에 부응할 뿐만 아니라, 세계 헬스케어의 안전성과 투명성에 대한 진화하는 기준에 부합할 수 있게 되었습니다.

세계 기침약 시장의 성장을 가속하는 주요 요인은?

기침약 시장의 성장은 지속적인 수요와 시장 확대를 보장하는 의료, 인구 통계, 환경 및 경제적 요인의 조합으로 인해 발생합니다. 기침은 매년 수백만 명이 앓고 있으며, 의사 방문 및 OTC 의약품 구매의 가장 흔한 이유 중 하나입니다. 공해, 계절성 알레르겐, 기후 변화와 같은 환경적 요인은 알레르기성 비염이나 기관지염과 같은 만성 호흡기 질환 증가에 기여하고 있습니다. 이와 함께 개발도상국의 인구 증가와 도시화, 특히 의료 서비스 접근성이 개선되고 의약품 유통 채널이 확대됨에 따라 기침약의 소비자 기반이 확대되고 있습니다. 전 세계적으로 건강 문해력이 향상되고 예방적 건강 관리 행동이 증가함에 따라 소비자들은 조기 증상 완화를 원하고 있으며, 이는 OTC 및 천연 기침약에 대한 수요를 증가시키고 있습니다. 또한, 온라인 플랫폼, 소매점, 약국 체인에서 제품을 구할 수 있게 됨에 따라, 특히 과거에는 접근성이 낮았던 지역에서 인지도가 높아지고 구매가 쉬워졌습니다. 전략적 마케팅, 유명인 추천, 의료 인플루언서와의 제휴도 소비자의 신뢰를 구축하고 브랜드 인지도를 높이는 데 일조하고 있습니다. 호흡기 건강이 세계 웰빙 인식의 최전선에 있는 가운데, 기침약 시장은 기존, 허브, 하이브리드 제품 카테고리에서 지속적인 성장이 예상됩니다.

부문

제품 유형(거담제, 항히스타민제, 기관지 확장제, 충혈 제거제, 항생제), 연령층(소아, 성인), 유통 채널(소매 약국, 병원 약국, 온라인 약국)

조사 대상 기업 예(총 47개사)

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Bristol Myers Squibb
  • Douglas Pharmaceuticals
  • Eisai Co., Ltd.
  • GSK plc
  • Haleon plc
  • Johnson & Johnson
  • Kyowa Kirin Co., Ltd.
  • Merck KGaA
  • Perrigo Company plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Ricola Ltd.
  • Sanofi S.A.
  • Takeda Pharmaceutical Co.
  • Teva Pharmaceutical Industries Ltd.
  • Vicks(Procter & Gamble)
  • Wockhardt Ltd.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 인위적인 수익원가 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

Global Industry Analysts는 세계 주요 수석 이코노미스트(1,4,949명), 싱크탱크(62개 기관), 무역 및 산업 단체(171개 기관)의 전문가들의 의견을 면밀히 검토하여 생태계에 미치는 영향을 평가하고 새로운 시장 현실에 대응하고 있습니다. 모든 주요 국가의 전문가와 경제학자들이 관세와 그것이 자국에 미치는 영향에 대한 의견을 추적 조사했습니다.

Global Industry Analysts는 이러한 혼란이 향후 2-3개월 내에 마무리되고 새로운 세계 질서가 보다 명확하게 확립될 것으로 예상하고 있으며, Global Industry Analysts는 이러한 상황을 실시간으로 추적하고 있습니다.

2025년 4월: 협상 단계

이번 4월 보고서에서는 관세가 세계 시장 전체에 미치는 영향과 지역별 시장 조정에 대해 소개합니다. 당사의 예측은 과거 데이터와 진화하는 시장 영향요인을 기반으로 합니다.

2025년 7월: 최종 관세 재설정

고객님들께는 각 국가별 최종 리셋이 발표된 후 7월에 무료 업데이트 버전을 제공해 드립니다. 최종 업데이트 버전에는 명확하게 정의된 관세 영향 분석이 포함되어 있습니다.

상호 및 양자 간 무역과 관세의 영향 분석 :

미국 <>& 중국 <>& 멕시코 <>& 캐나다 <>&EU <>& 일본 <>& 인도 <>& 기타 176개국

업계 최고의 이코노미스트: Global Industry Analysts의 지식 기반은 국가, 싱크탱크, 무역 및 산업 단체, 대기업, 그리고 세계 계량 경제 상황의 전례 없는 패러다임 전환의 영향을 공유하는 분야별 전문가 등 가장 영향력 있는 수석 이코노미스트 그룹을 포함한 14,949명의 이코노미스트를 추적하고 있습니다. 16,491개 이상의 보고서 대부분에 마일스톤에 기반한 2단계 출시 일정을 적용하고 있습니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.06.18

Global Cough Remedy Market to Reach US$1.2 Billion by 2030

The global market for Cough Remedy estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.2 Billion by 2030, growing at a CAGR of 2.6% over the analysis period 2024-2030. Expectorants, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$573.3 Million by the end of the analysis period. Growth in the Antihistamine segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$281.2 Million While China is Forecast to Grow at 5.1% CAGR

The Cough Remedy market in the U.S. is estimated at US$281.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$233.0 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 2.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global Cough Remedy Market - Key Trends & Drivers Summarized

Why Are Cough Remedies an Enduring Segment in Global Healthcare and Wellness Markets?

Cough remedies continue to be a vital component of over-the-counter (OTC) healthcare products due to the universal and recurrent nature of coughs across all age groups and geographies. Whether triggered by the common cold, allergies, asthma, flu, or environmental pollutants, coughs are among the most common symptoms prompting individuals to seek relief. This enduring demand ensures a steady market for cough syrups, lozenges, expectorants, decongestants, and combination remedies. The accessibility of OTC cough medications in pharmacies, supermarkets, and online platforms makes them one of the most purchased self-care solutions globally. Additionally, rising health awareness has led to increased early treatment of respiratory symptoms, prompting more consumers to keep cough remedies in their household medicine cabinets year-round. Seasonal surges in respiratory infections-especially during winter and flu seasons-consistently drive spikes in demand. Pediatric and geriatric populations, in particular, rely heavily on mild and specialized formulations that can soothe symptoms without strong side effects. Furthermore, the market has evolved to include herbal, natural, and sugar-free variants, catering to the growing preferences for gentle and holistic healthcare. As both a frontline symptom-reliever and a product deeply embedded in daily wellness routines, cough remedies remain an essential and high-volume category in global pharmaceutical and consumer health portfolios.

How Are Shifting Consumer Preferences and Lifestyle Trends Influencing the Cough Remedy Market?

The cough remedy market is increasingly shaped by modern consumer behavior, which favors fast-acting, non-drowsy, natural, and personalized treatment options. As consumers become more ingredient-conscious, there is a marked shift toward remedies that feature natural components such as honey, ginger, menthol, eucalyptus, ivy leaf, and licorice root-often perceived as safer and gentler alternatives to chemical-based medicines. This trend is particularly pronounced among millennials and parents of young children, who prefer natural formulations with fewer synthetic additives. Busy lifestyles are also driving demand for portable and easy-to-use formats, such as dissolvable strips, lozenges, and single-dose sachets. In tandem, digital wellness culture and self-diagnosis habits have empowered consumers to self-select remedies based on symptom specificity, encouraging brands to offer clearly segmented products (e.g., dry cough vs. chesty cough, daytime vs. nighttime). Vegan, sugar-free, gluten-free, and alcohol-free labels are further enhancing appeal across various dietary and ethical consumer groups. In the wake of COVID-19, heightened awareness around respiratory health has led to more cautious behavior, with individuals more likely to treat mild symptoms preemptively. These evolving preferences are encouraging pharmaceutical companies and wellness brands to innovate with cleaner labels, multifunctional benefits, and user-friendly delivery systems-reshaping how cough remedies are formulated, marketed, and consumed.

What Innovations and Regulatory Developments Are Shaping the Efficacy and Safety of Cough Remedies?

Innovation in the cough remedy market is advancing on multiple fronts, from pharmacological formulations and botanical research to regulatory oversight and manufacturing technology. Scientists and manufacturers are continually exploring new active ingredients-both synthetic and plant-derived-to enhance efficacy while minimizing side effects such as drowsiness or gastrointestinal discomfort. Modern formulations often combine multiple actions (expectorant, antihistamine, antitussive) in a single dose to simplify treatment and increase patient compliance. Furthermore, encapsulation and time-release technologies are being developed to prolong the therapeutic effects of ingredients, reducing the frequency of doses and improving convenience. On the regulatory side, agencies such as the FDA (U.S.), EMA (Europe), and MHRA (UK) have tightened controls on specific ingredients like codeine and dextromethorphan due to concerns around misuse, particularly among adolescents. As a result, there is an increasing emphasis on safe, non-habit-forming alternatives and clearer dosage labeling. Quality certifications such as GMP (Good Manufacturing Practice) and ISO standards are now baseline requirements for both conventional and herbal remedy producers. In emerging markets, improved regulatory frameworks and increased public health investment are enabling the introduction of more reliable, tested, and compliant products. Together, these developments are ensuring that cough remedies not only meet modern expectations for effectiveness but also align with evolving standards of safety and transparency in global healthcare.

What Are the Primary Drivers Fueling the Growth of the Global Cough Remedy Market?

The growth in the cough remedy market is driven by a combination of medical, demographic, environmental, and economic factors that ensure sustained demand and market expansion. One of the core drivers is the persistent prevalence of upper respiratory tract infections worldwide, which continue to affect millions annually and remain one of the most common reasons for doctor visits and OTC purchases. Environmental triggers such as pollution, seasonal allergens, and climate change are contributing to an increase in chronic respiratory conditions like allergic rhinitis and bronchitis-conditions where cough is a frequent symptom. In parallel, population growth and urbanization in developing countries are expanding the consumer base for cough remedies, especially as healthcare access improves and pharmaceutical distribution channels deepen. The global rise in health literacy and preventive healthcare behaviors is encouraging consumers to seek early symptom relief, which boosts demand for OTC and natural cough medications. Furthermore, product availability across online platforms, retail stores, and pharmacy chains is increasing visibility and ease of purchase, especially in previously underserved regions. Strategic marketing, celebrity endorsements, and medical influencer partnerships are also playing a role in building consumer trust and driving brand recognition. With respiratory health at the forefront of global wellness consciousness, the market for cough remedies is poised for continued growth across conventional, herbal, and hybrid product categories.

SCOPE OF STUDY:

The report analyzes the Cough Remedy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Expectorants, Antihistamine, Bronchodilator, Decongestant, Antibiotic); Age Group (Pediatric, Adult); Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Bristol Myers Squibb
  • Douglas Pharmaceuticals
  • Eisai Co., Ltd.
  • GSK plc
  • Haleon plc
  • Johnson & Johnson
  • Kyowa Kirin Co., Ltd.
  • Merck KGaA
  • Perrigo Company plc
  • Pfizer Inc.
  • Reckitt Benckiser Group plc
  • Ricola Ltd.
  • Sanofi S.A.
  • Takeda Pharmaceutical Co.
  • Teva Pharmaceutical Industries Ltd.
  • Vicks (Procter & Gamble)
  • Wockhardt Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Cough Remedy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Respiratory Infections Throws the Spotlight on Fast-Acting Cough Relief Products
    • Consumer Shift Toward Herbal and Natural Remedies Drives Demand for Plant-Based Cough Treatments
    • Surge in Pediatric and Geriatric Populations Propels Growth in Age-Specific Cough Formulations
    • Expansion of E-Commerce Channels Accelerates Availability and Market Penetration of OTC Cough Remedies
    • Seasonal Allergies and Urban Pollution Trends Strengthen the Business Case for Chronic Cough Relief Solutions
    • Push for Sugar-Free and Alcohol-Free Formulations Drives Innovation in Health-Conscious Syrups and Lozenges
    • Increased Awareness of Antimicrobial Resistance Spurs Preference for Non-Antibiotic Cough Relief Options
    • Growth in Functional Beverages and Gummies Expands Format Diversity in the Cough Remedy Market
    • Focus on Respiratory Health Consciousness Sustains Long-Term Demand for Immune-Supportive Cough Products
    • Pharmacy Chains and Private Label Expansion Drive Competitive Pricing in Key Cough Remedy Segments
    • Rise in Travel Generates Demand for Portable, Travel-Sized Cough Relief SKUs
    • Rising Demand for Rapid-Onset Relief Enhances the Appeal of Fast-Dissolving and Inhalable Cough Formats
    • Integration of Traditional Medicine Practices Spurs Growth in Ayurveda, TCM, and Homeopathy-Based Formulations
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cough Remedy Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cough Remedy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Expectorants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Expectorants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Expectorants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Antihistamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Antihistamine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Antihistamine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Bronchodilator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Bronchodilator by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Bronchodilator by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Decongestant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Decongestant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Decongestant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Antibiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Antibiotic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Antibiotic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Online Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Online Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospital Pharmacy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospital Pharmacy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Pediatric by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Pediatric by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Adult by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Adult by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • JAPAN
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • CHINA
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • EUROPE
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Cough Remedy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • FRANCE
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • GERMANY
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Cough Remedy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • INDIA
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Cough Remedy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Cough Remedy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Cough Remedy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030
  • AFRICA
    • Cough Remedy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Cough Remedy by Product Type - Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Cough Remedy by Product Type - Percentage Breakdown of Value Sales for Expectorants, Antihistamine, Bronchodilator, Decongestant and Antibiotic for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Cough Remedy by Distribution Channel - Online Pharmacy, Retail Pharmacy and Hospital Pharmacy Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Cough Remedy by Distribution Channel - Percentage Breakdown of Value Sales for Online Pharmacy, Retail Pharmacy and Hospital Pharmacy for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Cough Remedy by Age Group - Pediatric and Adult - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Cough Remedy by Age Group - Pediatric and Adult Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Cough Remedy by Age Group - Percentage Breakdown of Value Sales for Pediatric and Adult for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제